News

Technology News

Constellation Pharma Is AlwaysOn Top 100

Friday, October 09, 2009 5:16:00 AM PDT | VentureDeal Staff
Cambridge, Massachusetts  --  Human genome biopharmaceutical company Constellation Pharmaceuticals has been selected by AlwaysOn as an OnDC Top 100 winner.

Constellation is developing novel drugs that are targeting selective regulators of epigenetic function in the human body.

The company recently closed a $32 million series A venture capital financing and is continuing to build its preclinical pipeline of epigenetic drugs.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1